Recent Press Releases
| DATE |
TITLE (click to view) |
| December 23, 2008 | Antigenics Receives NASDAQ Delisting Notice |
| November 26, 2008 | Antigenics Receives NASDAQ Delisting Notification |
| November 24, 2008 | Final Data From Phase 1 Investigator-Sponsored Trial of Oncophage® Cancer Vaccine in Glioma Presented at the Society for Neuro-Oncology’s Annual Meeting |
| November 5, 2008 | Antigenics Reports Third Quarter 2008 Financial Results |
| November 3, 2008 | Antigenics to Present at the Rodman and Renshaw 10th Annual Healthcare Conference |
| October 31, 2008 | Antigenics to Report Third Quarter 2008 Financial Results on November 5, 2008; Conference Call to Follow |
| October 22, 2008 | Antigenics Submits Oncophage® Application for European Approval |
| September 29, 2008 | FDA Grants Permission For Export of Antigenics’ Oncophage to Russia |
| September 15, 2008 | Antigenics to Present at the UBS 2008 Global Life Sciences Conference |
| July 31, 2008 | Antigenics Reports Second Quarter 2008 Financial Results |
| July 24, 2008 | Antigenics To Report Second Quarter 2008 Financial Results on July 31, 2008; Conference Call To Follow |
| May 21, 2008 | Antigenics To Webcast 2008 Annual Shareholders Meeting |
| May 13, 2008 | Antigenics To Present At Rodman & Renshaw 5th Annual Global Healthcare Conference |
| May 1, 2008 | Antigenics Reports First Quarter 2008 Financial Results |
| April 24, 2008 | Antigenics To Report First Quarter 2008 Financial Results On May 1, 2008; Conference Call To Follow |
|
|
|
|
|
